resveratrol has been researched along with Hypoxia in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (8.33) | 29.6817 |
2010's | 34 (56.67) | 24.3611 |
2020's | 21 (35.00) | 2.80 |
Authors | Studies |
---|---|
Alessio, N; Ambruosi, M; Banoglu, E; Boccellino, M; Bruno, F; De Rosa, M; Donniacuo, M; Filosa, R; Fiorentino, A; Kahn, H; Massa, A; Olgaç, A; Pace, S; Quagliuolo, L; Rinaldi, B; Werz, O | 1 |
Bai, S; Dai, H; Fang, L; Huang, L; Luo, H; Tan, X; Wu, H; Xu, L; Ye, Y | 1 |
Decheng, B; Lixia, Z; Wei, S | 1 |
Cui, H; Li, Q; Li, X; Yang, Y; Zong, W | 1 |
Ai, C; Chen, Z; Li, R; Liu, W; Pu, L; Wang, T; Wang, X; Wang, Z; Xu, H; Yan, C; Zhang, B; Zhang, X | 1 |
Chen, D; Chen, X; Dong, Z; He, X; Li, J; Li, M; Li, T; Liu, Y; Tao, Y; Wang, Y; Zang, S; Zhao, Z | 1 |
Dhyani, V; Giri, L; Gupta, RK; Kaur, I; Majumdar, S; Pant, A; Saha, D; Sharma, S; Vishwakarma, S | 1 |
Chen, Y; Chu, Z; Li, W; Qin, D; Shu, P; Wang, Y; You, G; Zhao, L; Zhou, H | 1 |
Borkowska, A; Brodaczewska, K; Filipiak-Duliban, A; Gawrylak, A; Kieda, C; Kominek, A; Kubiak, JZ; Lewicki, S; Majewska, A; Piwocka, K; Siewiera, J; Synowiec, A; Szczylik, C; Szenajch, J; Waś, H; Wcisło, G; Wilkus, K | 1 |
Chen, ZL; Guo, CJ; Liang, LL; Liu, H; Pan, CY; Wang, XX; Zhang, BY | 1 |
Deng, K; Jiang, Z; Li, E; Li, G; Li, X; Lian, J; Qu, C; Ren, Y; Shen, T; Sun, X; Wang, X; Wang, Z | 1 |
Guan, P; Ji, ES; Luo, LF; Sun, ZM; Wang, N; Zhao, YS; Zhou, J | 1 |
Cheng, YC; Chiang, MC; Lin, CH; Nicol, CJB; Wang, YS; Yen, C | 1 |
Guo, J; Li, H; Li, X; Liu, Z; Shi, R; Sun, Y; Wang, Y; Wu, S; Yin, H | 1 |
Huang, J; Lian, N; Lin, Q; Lin, T; Zhang, S | 1 |
Li, C; Long, J; Peng, G; Xiao, P; Yang, H; Zeng, X | 1 |
Guan, P; Ji, ES; Luo, LF; Qin, LY; Sun, ZM; Wang, N; Zhao, YS | 1 |
Beauvieux, MC; Bouzier-Sore, AK; Chateil, JF; Deffieux, D; Dumont, U; Olivier, B; Pellerin, L; Quideau, S; Roumes, H; Sanchez, S | 1 |
Chen, Z; Deng, B; Du, L; Duan, R; Gao, Z; Liu, W; Pu, L; Wang, T; Wang, X; Wang, Z | 1 |
Guo, SJ; He, GM; He, LN; Lan, YR; Wang, T; Wen, FQ | 1 |
Bai, R; Feng, L; Gao, Y; He, X; Lan, F; Liu, X; Shi, J; Song, F; Tian, M; Tu, M; Wang, J; Yao, Y; Zhang, H; Zhou, J; Zhou, R | 1 |
Chen, G; Chen, S; Fan, Y; Hao, X; Qin, Z; Qu, H; Sun, X; Zhao, B | 1 |
Han, X; Li, Q; Li, Y; Liu, Y; Lu, Y; Mao, J; Zhang, W | 1 |
Chen, HP; Duan, GL; Li, XR; Xiao, L; Zhang, Y; Zhao, L | 1 |
Hao, T; Li, YY; Liu, YH; Lu, Y | 1 |
Li, X; Liu, X; Ma, X; Tan, Y; Wu, J; Xie, J; Zhao, Y; Zhou, Y | 1 |
Chen, L; Li, P; Li, T; Tan, XQ; Yang, B; Yu, Y | 1 |
Agrawal, M; Kashyap, MP; Khanna, VK; Kumar, V; Pant, AB; Siddiqui, MA; Singh, AK | 1 |
Cullberg, KB; Foldager, CB; Lind, M; Olholm, J; Paulsen, SK; Pedersen, SB; Richelsen, B | 1 |
Agrawal, SK; Atif, F; Kesherwani, V; Yousuf, S | 1 |
Han, J; Hanh, TM; Jeong, SH; Kim, HK; Kim, N; Ko, KS; Lee, SR; Noh, SJ; Rhee, BD; Song, IS; Song, S; Suh, H | 1 |
Li, Y; Liu, Y; Lu, Y | 1 |
Hu, CP; Li, TB; Liu, B; Luo, XJ; Ma, QL; Peng, J; Yang, ZB; Zhang, GG; Zhang, JJ; Zhang, XJ | 1 |
Anderson, RA; Panickar, KS; Qin, B | 1 |
Calvert, AE; Chen, B; Chicoine, LG; Meng, X; Slutzky, JL; Xue, J | 1 |
Ashida, H; Harada, N; Inui, H; Ito, Y; Mitani, T; Nakano, Y; Yamaji, R | 1 |
Dong, X; Li, P; Li, X; Sun, X; Wang, Q; Zhao, L | 1 |
Li, X; Liao, D; Lin, L; Zhang, R; Zuo, H | 1 |
Almendros, I; Carreras, A; Gozal, D; Peris, E; Qiao, Z; Wang, Y; Zhang, SX | 1 |
Fan, M; Huang, S; Jiang, Z; Sun, L; Yu, X; Zou, S; Zou, Y; Zuo, Q | 1 |
Woodworth, BA | 1 |
Gao, Y; Liu, D; Liu, G; Wang, Z; Wei, X; Xiu, M; Yuan, L; Zhang, Q | 1 |
Chi, TF; Dimova, EY; Ganjam, GK; Kietzmann, T | 1 |
Choi, EY; Chung, JH; Koh, HJ; Lee, CS; Lee, JH; Lee, SC | 1 |
Chen, HL; Chen, YH; Chong, IW; Hsieh, CC; Kuo, HF; Lee, YC; Liu, PL; Liu, WL; Tsai, JR; Wang, HM | 1 |
Abdel-Wahab, BA; Abdel-Wahab, MM | 1 |
Huang, F; Kou, J; Li, A; Li, J; Li, X; Liu, B; Liu, K; Qi, LW; Qiu, Z; Wang, L | 1 |
Chen, ZL; Deng, BN; Duan, RF; Jin, H; Li, PB; Nie, HJ; Zhu, HL | 1 |
Feng, H; Wang, H; Zhang, Y | 1 |
Feng, X; Hou, T; Li, A; Liu, B; Liu, K; Zhang, N; Zhao, W | 1 |
Choi, YJ; Heo, K; Jeong, MH; Park, HS; Yang, KM | 1 |
Dong, H; Dong, M; Li, Y; Li, Z; Liu, M; Liu, Y; Luo, Y; Niu, W; Wang, Y; Xu, D; Zhang, B; Zhao, P | 1 |
Baek, JH; Chae, HS; Han, DH; Hwang, HR; Kim, YH; Kwon, A; Lim, WH; Park, HJ; Yi, WJ | 1 |
Davidge, ST; Dolinsky, VW; Dyck, JR; Morton, JS; Rueda-Clausen, CF | 2 |
Eigel, BN; Gursahani, H; Hadley, RW | 1 |
Cao, AH; Goh, SS; Pepe, S; Qin, C; Ritchie, RH; Woodman, OL | 1 |
Dong, W; Gao, D; Zhang, X | 1 |
Büyükuysal, RL; Gürsoy, M | 1 |
Hsieh, SJ; Huang, HM; Jeng, KC; Kuo, JS; Wang, MJ | 1 |
1 review(s) available for resveratrol and Hypoxia
Article | Year |
---|---|
The physiological effects of resveratrol and its potential application in high altitude medicine.
Topics: Altitude; Humans; Hypoxia; Polycythemia; Resveratrol; Stilbenes | 2015 |
59 other study(ies) available for resveratrol and Hypoxia
Article | Year |
---|---|
Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Hypoxia; Lipoxygenase Inhibitors; Molecular Structure; Myocytes, Cardiac; Protective Agents; Rats; Stilbenes; Structure-Activity Relationship | 2019 |
L-arginine protects cementoblasts against hypoxia-induced apoptosis through Sirt1-enhanced autophagy.
Topics: Animals; Apoptosis; Arginine; Autophagy; Dental Cementum; Hypoxia; Mice; Rats; Resveratrol; Root Resorption; Sirtuin 1 | 2022 |
Protective effect of resveratrol on rat cardiomyocyte H9C2 cells injured by hypoxia/reoxygenation by regulating mitochondrial autophagy PTEN-induced putative kinase protein 1/Parkinson disease protein 2 signaling pathway.
Topics: Animals; Autophagy; Humans; Hypoxia; Mitochondrial Diseases; Myocytes, Cardiac; Parkinson Disease; Protein Kinases; PTEN Phosphohydrolase; Rats; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Ubiquitin-Protein Ligases; Ubiquitins | 2022 |
Resveratrol regulates paracrine function of cardiac microvascular endothelial cells under hypoxia/reoxygenation condition.
Topics: Apoptosis; Cells, Cultured; Endothelial Cells; Humans; Hypoxia; Myocardial Reperfusion Injury; Resveratrol | 2022 |
Resveratrol Ameliorates High Altitude Hypoxia-Induced Osteoporosis by Suppressing the ROS/HIF Signaling Pathway.
Topics: Alkaline Phosphatase; Altitude Sickness; Animals; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Hypoxia; Male; Osteocalcin; Osteogenesis; Osteoporosis; Rats; Rats, Wistar; Reactive Oxygen Species; Resveratrol; Signal Transduction | 2022 |
Cellular Hypoxia Mitigation by Dandelion-like Nanoparticles for Synergistic Photodynamic Therapy of Oral Squamous Cell Carcinoma.
Topics: Adenosine Triphosphate; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; ErbB Receptors; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Hypoxia; Ligands; Micelles; Mouth Neoplasms; Nanogels; Nanoparticles; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Resveratrol; Squamous Cell Carcinoma of Head and Neck | 2022 |
Non-prophylactic resveratrol-mediated protection of neurite integrity under chronic hypoxia is associated with reduction of Cav1.2 channel expression and calcium overloading.
Topics: Animals; Calcium; Calcium Channels, L-Type; Hypoxia; Neurites; Neurons; Resveratrol | 2023 |
Resveratrol, a New Allosteric Effector of Hemoglobin, Enhances Oxygen Supply Efficiency and Improves Adaption to Acute Severe Hypoxia.
Topics: Animals; Hemoglobins; Hypoxia; Mice; Molecular Docking Simulation; Oxygen; Rats; Resveratrol | 2023 |
Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.
Topics: Cell Hypoxia; Cell Line, Tumor; Cisplatin; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ovarian Neoplasms; Resveratrol; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2023 |
[Effects of three Polyphenolic compounds on the intestinal flora of mice exposed simulated intermittent plateau hypoxia].
Topics: Animals; Anthocyanins; Bacteria; Gastrointestinal Microbiome; Hypoxia; Male; Mice; Quercetin; Resveratrol; RNA, Ribosomal, 16S | 2022 |
Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH/GPX4 pathway.
Topics: Animals; Caco-2 Cells; Catalase; Ferroptosis; Humans; Hypoxia; Mice; Reactive Oxygen Species; Reperfusion Injury; Resveratrol; Sirtuin 3 | 2023 |
Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cardiomegaly; Gene Expression Regulation; Hypoxia; Male; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Neuroprotective effects of resveratrol against oxygen glucose deprivation induced mitochondrial dysfunction by activation of AMPK in SH-SY5Y cells with 3D gelatin scaffold.
Topics: AMP-Activated Protein Kinases; Apoptosis; Cell Line, Tumor; Cell Survival; Gelatin; Humans; Hypoglycemia; Hypoxia; Mitochondria; Neuroprotective Agents; Resveratrol; Signal Transduction | 2020 |
Resveratrol reserved hypoxia-ischemia induced childhood hippocampal dysfunction and neurogenesis via improving mitochondrial dynamics.
Topics: Animals; Animals, Newborn; Hippocampus; Hypoxia; Hypoxia-Ischemia, Brain; Ischemia; Maze Learning; Mice; Mitochondrial Dynamics; Neurogenesis; Resveratrol | 2020 |
Resveratrol Attenuates Intermittent Hypoxia-Induced Lung Injury by Activating the Nrf2/ARE Pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidant Response Elements; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Disease Models, Animal; Heme Oxygenase (Decyclizing); Hypoxia; Inflammation Mediators; Interleukin-6; Lung; Lung Injury; Male; NF-E2-Related Factor 2; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Tumor Necrosis Factor-alpha | 2020 |
Protective effects of resveratrol and SR1001 on hypoxia-induced pulmonary hypertension in rats.
Topics: Animals; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Hypertension, Pulmonary; Hypoxia; Male; Protein Phosphatase 1; Pulmonary Artery; Rats; Resveratrol; rhoA GTP-Binding Protein; Sulfonamides; Th17 Cells; Thiazoles; Treatment Outcome | 2020 |
Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation.
Topics: Animals; Antioxidants; Blotting, Western; Echocardiography; Fluorescent Antibody Technique; Hypoxia; Inflammasomes; Male; Myocardial Ischemia; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol | 2020 |
Maternal alcoholism and neonatal hypoxia-ischemia: Neuroprotection by stilbenoid polyphenols.
Topics: Alcohol Drinking; Alcoholism; Animals; Animals, Newborn; Brain; Brain Injuries; Cognitive Dysfunction; Female; Hypoxia; Hypoxia-Ischemia, Brain; Ischemia; Male; Maternal Nutritional Physiological Phenomena; Maternal-Fetal Exchange; Neuroprotection; Neuroprotective Agents; Polyphenols; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2020 |
Quantitative Proteomics Reveals the Effects of Resveratrol on High-Altitude Polycythemia Treatment.
Topics: Adaptation, Physiological; Altitude; Altitude Sickness; Animals; Antioxidants; Erythrocytes; Hypoxia; Male; Polycythemia; Proteome; Rats; Rats, Wistar; Resveratrol; Transcriptome | 2020 |
[Resveratrol inhibits hypoxia-induced oxidative stress and proliferation in pulmonary artery smooth muscle cells through the HIF-1α/NOX4/ROS signaling pathway].
Topics: Animals; Cell Proliferation; Cells, Cultured; Hypoxia; Myocytes, Smooth Muscle; NADPH Oxidase 4; Oxidative Stress; Pulmonary Artery; Rats; Reactive Oxygen Species; Resveratrol; Signal Transduction | 2020 |
Resveratrol promotes the survival and neuronal differentiation of hypoxia-conditioned neuronal progenitor cells in rats with cerebral ischemia.
Topics: Animals; Brain Ischemia; Cell Differentiation; Hypoxia; Neurons; Rats; Resveratrol | 2021 |
Sera and lungs metabonomics reveals key metabolites of resveratrol protecting against PAH in rats.
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Disease Models, Animal; Energy Metabolism; Hypoxia; Lung; Male; Metabolomics; Pulmonary Arterial Hypertension; Rats, Wistar; Resveratrol; Spectrometry, Mass, Electrospray Ionization | 2021 |
Downregulated hypoxia-inducible factor 1α improves myoblast differentiation under hypoxic condition in mouse genioglossus.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Differentiation; Dimerization; Down-Regulation; Gene Expression Regulation; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred C57BL; Mitochondria; Muscle, Skeletal; Nuclear Proteins; Resveratrol; RNA, Small Interfering; Transcription Factors; Up-Regulation | 2021 |
DJ-1 preserving mitochondrial complex I activity plays a critical role in resveratrol-mediated cardioprotection against hypoxia/reoxygenation-induced oxidative stress.
Topics: Animals; Cardiotonic Agents; Cell Line; Electron Transport Complex I; Hypoxia; L-Lactate Dehydrogenase; Mitochondria; Myocytes, Cardiac; Oxidative Stress; Protein Deglycase DJ-1; Rats; Reactive Oxygen Species; Reperfusion Injury; Resveratrol; RNA, Small Interfering; Stilbenes | 2018 |
[Effect of 17β-estradiol or resveratrol dimer on hypoxia inducible factor-1α in genioglossus myoblasts and its mechanism].
Topics: Animals; Estradiol; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Myoblasts; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol | 2018 |
Resveratrol Abrogates Hypoxia-Induced Up-Regulation of Exosomal Amyloid-β Partially by Inhibiting CD147.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Basigin; Hippocampus; Hypoxia; Male; Mice, Inbred C57BL; Peptide Fragments; Resveratrol; Transcriptional Activation; Up-Regulation | 2019 |
Resveratrol alleviates hypoxia/reoxygenation injury‑induced mitochondrial oxidative stress in cardiomyocytes.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Caspase 3; Cell Hypoxia; Hypoxia; Membrane Potential, Mitochondrial; Mitochondria; Myocytes, Cardiac; Oxidative Stress; Rats; Resveratrol; Sirtuin 1 | 2019 |
trans-Resveratrol protects ischemic PC12 Cells by inhibiting the hypoxia associated transcription factors and increasing the levels of antioxidant defense enzymes.
Topics: Animals; Antioxidants; Calcium; Calcium Channels; Cell Death; Cell Hypoxia; HSP27 Heat-Shock Proteins; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; L-Lactate Dehydrogenase; PC12 Cells; Rats; Reactive Oxygen Species; Resveratrol; STAT3 Transcription Factor; Stilbenes; Superoxide Dismutase; Superoxide Dismutase-1; TRPM Cation Channels | 2013 |
Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro.
Topics: Adipose Tissue; Adult; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Female; Glucose Transporter Type 1; Humans; Hypoxia; In Vitro Techniques; Inflammation; Interleukin-6; Interleukin-8; Leptin; Neovascularization, Physiologic; Resveratrol; RNA, Messenger; Stilbenes; Vascular Endothelial Growth Factor A | 2013 |
Resveratrol protects spinal cord dorsal column from hypoxic injury by activating Nrf-2.
Topics: Animals; Antioxidants; Blotting, Western; Fluorescent Antibody Technique; Hypoxia; Immunohistochemistry; Male; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Spinal Cord; Spinal Cord Injuries; Stilbenes | 2013 |
HS-1793, a recently developed resveratrol analogue protects rat heart against hypoxia/reoxygenation injury via attenuating mitochondrial damage.
Topics: Animals; Calcium; Heart; Hypoxia; Mitochondria; Myocardial Reperfusion Injury; Naphthols; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resorcinols; Resveratrol; Stilbenes | 2013 |
Comparison of natural estrogens and synthetic derivative on genioglossus function and estrogen receptors expression in rats with chronic intermittent hypoxia.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Estradiol; Estradiol Congeners; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Genistein; Hypoxia; Indenes; Muscle Contraction; Muscle Fatigue; Muscle, Skeletal; Myoblasts, Skeletal; Rats; Rats, Sprague-Dawley; Resorcinols; Resveratrol; Sleep Apnea, Obstructive; Stilbenes; Tongue | 2014 |
Inhibition of NOX/VPO1 pathway and inflammatory reaction by trimethoxystilbene in prevention of cardiovascular remodeling in hypoxia-induced pulmonary hypertensive rats.
Topics: Animals; Hemeproteins; Hypertension, Pulmonary; Hypoxia; Inflammation; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Peroxidases; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes; Ventricular Remodeling | 2014 |
Ischemia-induced endothelial cell swelling and mitochondrial dysfunction are attenuated by cinnamtannin D1, green tea extract, and resveratrol in vitro.
Topics: Animals; Antioxidants; Brain Ischemia; Calcium; Cell Line; Chemokine CCL2; Cyclosporine; Egtazic Acid; Endothelial Cells; Glucose; Hypoxia; Interleukin-6; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Plant Extracts; Polyphenols; Proanthocyanidins; Reactive Oxygen Species; Resveratrol; Stilbenes; Tea; Tumor Necrosis Factor-alpha | 2015 |
Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling.
Topics: Animals; Arginase; Cell Proliferation; Cells, Cultured; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Myocytes, Smooth Muscle; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Stilbenes | 2014 |
Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells.
Topics: Alcohol Oxidoreductases; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; MCF-7 Cells; Phytotherapy; Plant Extracts; Resveratrol; RNA, Messenger; Stilbenes | 2014 |
Resveratrol attenuates intermittent hypoxia-induced insulin resistance in rats: involvement of Sirtuin 1 and the phosphatidylinositol-4,5-bisphosphate 3-kinase/AKT pathway.
Topics: Animals; Blood Glucose; Body Weight; Gene Expression Regulation; Glucose Transporter Type 2; Hypoxia; Insulin; Insulin Resistance; Liver; Male; Phosphatidylinositol 3-Kinases; Phosphorylation; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Receptor, Insulin; Resveratrol; RNA, Messenger; Signal Transduction; Sirtuin 1; Stilbenes | 2015 |
[Resveratrol attenuates hypoxia-reperfusion injury induced rat myocardium microvascular endothelial cell dysfunction through upregulating PI3K/Akt/SVV pathways].
Topics: Animals; Apoptosis; Cell Proliferation; Chromones; Endothelial Cells; Enzyme Inhibitors; Heart; Hypoxia; Morpholines; Myocardium; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes; Up-Regulation | 2014 |
Resveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice.
Topics: Animals; Anti-Obesity Agents; Drug Evaluation, Preclinical; Eating; Hypoxia; Insulin; Insulin Resistance; Intra-Abdominal Fat; Leptin; Macrophages; Male; Mice, Inbred C57BL; Random Allocation; Resveratrol; Stilbenes; Weight Gain | 2015 |
Resveratrol inhibits trophoblast apoptosis through oxidative stress in preeclampsia-model rats.
Topics: Animals; Antioxidants; Apoptosis; Blood Pressure; Cell Line; Disease Models, Animal; Female; Hypoxia; Oxidative Stress; Phenotype; Placenta; Pre-Eclampsia; Pregnancy; Rats; Resveratrol; Stilbenes; Trophoblasts | 2014 |
Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport, Active; Cells, Cultured; Chloride Channels; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; HEK293 Cells; Humans; Hypoxia; Ion Transport; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Models, Biological; Mucociliary Clearance; Nasal Mucosa; Paranasal Sinuses; Patch-Clamp Techniques; Phosphorylation; Resveratrol; Stilbenes; Swine | 2015 |
Resveratrol attenuates hypoxia-induced neurotoxicity through inhibiting microglial activation.
Topics: Animals; Cell Line; Cells, Cultured; Hypoxia; Interleukin-1beta; Mice; Microglia; Mitogen-Activated Protein Kinases; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2015 |
Resveratrol: beneficial or not? Opposite effects of resveratrol on hypoxia-dependent PAI-1 expression in tumour and primary cells.
Topics: Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hepatocytes; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Oxygen; Plasminogen Activator Inhibitor 1; Polyphenols; Resveratrol; RNA, Messenger; Stilbenes | 2016 |
Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization.
Topics: Adult; Animals; Cell Survival; Choroidal Neovascularization; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Resveratrol; Retinal Pigment Epithelium; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases; Ubiquitin; Vascular Endothelial Growth Factor A | 2015 |
Anti-inflammatory Effects of Resveratrol on Hypoxia/Reoxygenation-Induced Alveolar Epithelial Cell Dysfunction.
Topics: Anti-Inflammatory Agents; Cell Line; Epithelial Cells; Humans; Hypoxia; Interleukin-1beta; Interleukin-6; Lung Injury; Oxygen; Pulmonary Alveoli; Resveratrol; Stilbenes | 2015 |
Protective effect of resveratrol against chronic intermittent hypoxia-induced spatial memory deficits, hippocampal oxidative DNA damage and increased p47Phox NADPH oxidase expression in young rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Deoxyguanosine; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Glutamic Acid; Glutathione; Glutathione Reductase; Hemoglobins; Hippocampus; Hypoxia; Male; Maze Learning; Memory Disorders; NADPH Oxidases; Neuroprotective Agents; Rats; Rats, Wistar; Reaction Time; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances | 2016 |
The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Fibrosis; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Male; Metformin; Mice; Mice, Inbred ICR; Resveratrol; Stilbenes; Structure-Activity Relationship | 2016 |
Resveratrol inhibits hypoxia-induced glioma cell migration and invasion by the p-STAT3/miR-34a axis.
Topics: Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; Glioma; Humans; Hypoxia; Resveratrol; STAT3 Transcription Factor; Up-Regulation | 2016 |
Metformin and resveratrol ameliorate muscle insulin resistance through preventing lipolysis and inflammation in hypoxic adipose tissue.
Topics: 3T3-L1 Cells; Adipose Tissue; Administration, Oral; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diet, High-Fat; Diglycerides; Fatty Acids; Feeding Behavior; Glucose; Hypoxia; Inflammation; Insulin; Insulin Resistance; Lipolysis; Male; Metformin; Mice; Mice, Inbred ICR; Models, Biological; Muscles; Resveratrol; Signal Transduction; Stilbenes | 2016 |
The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Movement; Cell Survival; Enzyme-Linked Immunosorbent Assay; Female; Hypoxia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Naphthols; Neoplastic Stem Cells; Neovascularization, Pathologic; Radiation Tolerance; Radiation-Sensitizing Agents; Real-Time Polymerase Chain Reaction; Resorcinols; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2016 |
Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats.
Topics: Animals; Antioxidants; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; NF-E2-Related Factor 2; Random Allocation; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Thioredoxins | 2016 |
The effect of antioxidants on the production of pro-inflammatory cytokines and orthodontic tooth movement.
Topics: Acetylcysteine; Animals; Antioxidants; Cells, Cultured; Fibroblasts; Humans; Hypoxia; Inflammation; Inflammation Mediators; Interleukin-1beta; Male; Molar; Periodontal Ligament; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Stress, Mechanical; Tooth Mobility; Tumor Necrosis Factor-alpha; Up-Regulation | 2011 |
Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted.
Topics: Animals; Antioxidants; Body Weight; Calorimetry, Indirect; Dietary Fats; Energy Intake; Female; Fetal Growth Retardation; Hypoxia; Insulin Resistance; Male; Metabolic Syndrome; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol; Stilbenes | 2011 |
Synergistic effects of prenatal hypoxia and postnatal high-fat diet in the development of cardiovascular pathology in young rats.
Topics: Animals; Blood Pressure; Body Weight; Diet, High-Fat; Female; Fetal Growth Retardation; Heart; Heart Rate; Hypoxia; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2012 |
ROS are required for rapid reactivation of Na+/Ca2+ exchanger in hypoxic reoxygenated guinea pig ventricular myocytes.
Topics: Animals; Antioxidants; Cells, Cultured; Chromans; Diazoxide; Free Radical Scavengers; Guinea Pigs; Heart Ventricles; Hypoxia; Metalloporphyrins; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Sodium-Calcium Exchanger; Stilbenes | 2004 |
The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms.
Topics: Animals; Antioxidants; Carotid Arteries; Dose-Response Relationship, Drug; Endothelial Cells; Heart; Humans; Hypoxia; In Vitro Techniques; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes | 2007 |
Mitochondria biogenesis induced by resveratrol against brain ischemic stroke.
Topics: Animals; Antioxidants; Brain Ischemia; DNA, Mitochondrial; Flavonoids; Humans; Hypoxia; Mice; Mitochondria; Models, Biological; Phenols; Polyphenols; Reactive Oxygen Species; Reperfusion Injury; Resveratrol; Stilbenes; Stroke | 2007 |
Resveratrol protects rat striatal slices against anoxia-induced dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Animals; Antioxidants; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Female; Hypoxia; Male; Nomifensine; Ouabain; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2008 |
Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia/hypoglycemia followed by reoxygenation.
Topics: Animals; Antioxidants; Cerebral Cortex; Hyperglycemia; Hypoxia; Interleukin-6; Neuroglia; NF-kappa B; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes | 2001 |